CLS(CLS)
CLS
Q4 2026 EPS Estimate
$3.04
Oct 26, 2026 · Reports after close
Revenue Estimate
$5.49B
FY2026E EPS$11.37
FY2027E EPS$19.87
Analyst Sentiment
Wall St. Consensus
Buy25 analysts·High coverage
67
Score
17 Buy (68%)8 Hold (32%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
1768%
Hold
832%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$406.00
+34.7%
Consensus
$460.00
+52.6%
Bull
$510.00
+69.2%
12-Month Target Range25 analysts
$406.00$460.00$510.00
Current $301.36Consensus
Current Price
$301.36
Upside to Consensus
$158.64
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+69.33%
EPS+74.71%
FY2028
Rev+32.34%
EPS+34.31%
FY2029
Rev+28.31%
EPS+30.26%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $20.57B | $34.84B | $46.11B | $59.16B |
| Low | $20.32B | $29.91B | $31.78B | $49.65B |
| High | $20.83B | $40.42B | $57.46B | $66.50B |
| EBITDA Avg | $1.43B | $2.42B | $3.20B | $4.11B |
| Low | $1.41B | $2.08B | $2.21B | $3.45B |
| High | $1.45B | $2.81B | $3.99B | $4.62B |
| EBIT Avg | $1.08B | $1.83B | $2.42B | $3.10B |
| Low | $1.07B | $1.57B | $1.67B | $2.60B |
| High | $1.09B | $2.12B | $3.01B | $3.49B |
| Net Income Avg | $1.32B | $2.28B | $3.01B | $4.04B |
| Low | $1.25B | $1.77B | $2.92B | $3.19B |
| High | $1.39B | $2.65B | $3.27B | $4.69B |
| EPS Avg | $11.37 | $19.87 | $26.68 | $34.76 |
| Low | $10.72 | $15.25 | $25.13 | $27.49 |
| High | $11.98 | $22.78 | $28.18 | $40.37 |
| Analysts (Rev / EPS) | 11 / 10 | 12 / 11 | 11 / 5 | 5 / 1 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $5.40B | $6.35B | $7.23B | $8.19B | $9.21B | $10.29B | $9.41B | $10.31B |
| Low | $5.33B | $6.16B | $7.12B | $8.07B | $9.07B | $10.13B | $9.27B | $10.16B |
| High | $5.54B | $6.69B | $7.42B | $8.40B | $9.44B | $10.55B | $9.65B | $10.57B |
| EBITDA Avg | $375M | $441M | $502M | $568M | $639M | $714M | $653M | $716M |
| Low | $370M | $428M | $495M | $560M | $630M | $704M | $644M | $705M |
| High | $385M | $464M | $515M | $583M | $655M | $732M | $670M | $734M |
| EBIT Avg | $284M | $333M | $379M | $430M | $483M | $540M | $494M | $541M |
| Low | $279M | $323M | $374M | $423M | $476M | $532M | $487M | $533M |
| High | $291M | $351M | $389M | $441M | $495M | $553M | $506M | $555M |
| Net Income Avg | $351M | $423M | $471M | $539M | $620M | $706M | $612M | $685M |
| Low | $326M | $401M | $462M | $528M | $608M | $693M | $600M | $672M |
| High | $371M | $465M | $486M | $557M | $640M | $730M | $632M | $708M |
| EPS Avg | $3.02 | $3.64 | $4.05 | $4.64 | $5.33 | $6.08 | $5.26 | $5.90 |
| Low | $2.80 | $3.45 | $3.97 | $4.55 | $5.23 | $5.96 | $5.16 | $5.78 |
| High | $3.19 | $4.00 | $4.18 | $4.79 | $5.51 | $6.28 | $5.44 | $6.09 |
| Analysts (Rev / EPS) | 8 / 10 | 8 / 9 | 4 / 6 | 5 / 3 | 4 / 3 | 5 / 6 | 3 / 8 | 4 / 4 |